STV analysis vs visual CTG check for fetal growth restriction
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This trial compares a new method (STV analysis) to the usual visual check of baby heart rate recordings (CTG) for pregnant people with severe early-onset fetal growth restriction. It aims to see if the new method helps doctors make better decisions about monitoring and delivery timing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant with one baby (not twins or more).
- Your pregnancy is between 24 weeks and 0 days and 31 weeks and 6 days.
- Your baby has severe early-onset fetal growth restriction (size much below normal for pregnancy stage, as confirmed by ultrasound).
- You are 18 years or older and can sign a consent form in a language you understand.
- Your baby does not have any known chromosome or birth defect that changes the expected outcome.
- You are not expected to go into labor or need delivery within the next 48 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how early, slow fetal growth is managed during pregnancy. It compares an “angiogenic factors” approach with an ultrasound (blood-flow) approach to help guide care and improve outcomes.
This study aims to better predict fetal growth restriction (when a baby doesn't grow as expected) in women who have certain risk factors. By joining, you may help doctors develop better screening tools for future pregnancies.
This study tests a new way to read your baby's heart rate tracing (cardiotocography) during labor when the tracing is not perfectly normal (category II). The goal is to see if this method helps doctors better manage labor and improve outcomes for you and your baby.
This study follows women whose babies have a growth problem in the womb (FGR) linked to how blood flows to the placenta. It looks at causes and outcomes to help improve care.
This trial studies whether a specific ultrasound approach can better detect problems with fetal (baby) growth in the later part of pregnancy. It may help identify concerns earlier so your care team can plan the next steps.
This study is testing a new way to find out early in pregnancy if you might be at risk for stillbirth. If you join, researchers will follow you through delivery to see if the screening tool helps improve outcomes.
Hear when a new Fetal Growth Retardation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.